Back
Speaker illustration

Doctor Julius Katzmann

University Hospital Leipzig, Leipzig (Germany)

Presentations

Triple oral lipid-lowering treatment pathway and associated outcomes in high- and very high-cv risk patients: a simulation using the SANTORINI study cohort

Event: ESC Congress 2025

Topic: Lipid-Lowering Agents

Session: Refining efficacy and safety of lipid-lowering pharmacotherapy

Access
Like
Thumbnail

Real-world effectiveness of bempedoic acid therapy on the reduction of low-density lipoprotein cholesterol levels in Germany

Event: ESC Congress 2025

Topic: Lipid-Lowering Agents

Session: Novel insights into lipid-lowering pharmacotherapy

Access
Like
Thumbnail

LDL cholesterol target attainment in a representative German cohort of high- and very-high-CV risk patients with statin intolerance: a simulation study

Event: ESC Congress 2023

Topic: Drug therapy

Session: Risk factors and prevention: lipids (5)

Access
Like
Thumbnail

Simulation study on LDL cholesterol target attainment, ASCVD events, and treatment cost of bempedoic acid in a representative German cohort of high- and very-high-CV risk patients

Event: ESC Congress 2022

Topic: Drug therapy

Session: Lipids - Drug therapy 2

Access
Like
Thumbnail

ESC 365 is supported by

bristol-myers-squibb Explore sponsored resources
novartis Explore sponsored resources